|
ABI1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.203700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.298400E-02 |
| Normal-vs-Stage2 |
5.981600E-01 |
| Normal-vs-Stage3 |
3.117400E-03 |
| Normal-vs-Stage4 |
1.412010E-02 |
| Stage1-vs-Stage2 |
5.288400E-01 |
| Stage1-vs-Stage3 |
1.617820E-01 |
| Stage1-vs-Stage4 |
3.866400E-01 |
| Stage2-vs-Stage3 |
1.452020E-01 |
| Stage2-vs-Stage4 |
2.891600E-01 |
| Stage3-vs-Stage4 |
6.736400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.180400E-03 |
| Normal-vs-AfricanAmerican |
4.563400E-04 |
| Normal-vs-Asian |
3.272600E-01 |
| Caucasian-vs-AfricanAmerican |
6.640100E-02 |
| Caucasian-vs-Asian |
1.844030E-01 |
| AfricanAmerican-vs-Asian |
2.572300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.339900E-02 |
| Normal-vs-Female |
4.540000E-03 |
| Male-vs-Female |
5.789800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.410300E-02 |
| Normal-vs-Age(41-60Yrs) |
7.941600E-02 |
| Normal-vs-Age(61-80Yrs) |
2.536100E-03 |
| Normal-vs-Age(81-100Yrs) |
9.920200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.692800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.727400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.819600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.870180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.510800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.224800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.712400E-01 |
| Normal-vs-Grade 2 |
2.346800E-01 |
| Normal-vs-Grade 3 |
7.835900E-04 |
| Normal-vs-Grade 4 |
2.481100E-03 |
| Grade 1-vs-Grade 2 |
5.784200E-01 |
| Grade 1-vs-Grade 3 |
1.833770E-01 |
| Grade 1-vs-Grade 4 |
5.337900E-02 |
| Grade 2-vs-Grade 3 |
4.381800E-02 |
| Grade 2-vs-Grade 4 |
5.160400E-02 |
| Grade 3-vs-Grade 4 |
4.363400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.115200E-01 |
| Normal-vs-ccB subtype |
2.583700E-03 |
| ccA subtype-vs-ccB subtype |
1.611880E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.931500E-02 |
| Normal-vs-N1 |
8.793200E-01 |
| N0-vs-N1 |
5.819000E-01 |
|
|
